Women involved in the carceral system (WICS) are at higher risk for both HIV and substance use than the general public. WICS are also more likely to engage in behaviors both before and after release that put them at risk for HIV and for overdose, due to opioid use. Despite these risk factors, WICS are less likely to be aware of, use, or adhere to pre-exposure prophylaxis (PrEP) and have less access to medications for opioid use disorder (MOUD). The primary goal of the proposed research is to pilot test a systematically developed PrEP and MOUD uptake intervention for WICS using contextually relevant messages developed through novel formative research methods and embedded in a web-based application in a rigorous research design. The investigators will then test this approach (called PA-LINKS) in a pilot randomized trial with women who have recently been incarcerated in Philadelphia in partnership with Philadelphia FIGHT, a federally qualified health center, for promise of efficacy, and to assess feasibility and acceptability.
The primary goal of the proposed research is to pilot test a systematically developed intervention for women who have been recently incarcerated to engage with pre-exposure prophalaxis (PrEP) and medication for opioid use disorder (MOUD) to prevent HIV infection and overdose. The intervention will use contextually relevant messages developed through novel formative research methods and be embedded in a web-based application called PA Links. The investigators will then test this approach in a pilot randomized trial with women who have recently been incarcerated. The purpose is to enhance communication in an existing post-release navigation model embedded in a community-based health services organization in Pennsylvania (Philadelphia FIGHT) to increase PrEP and MOUD uptake. The app is meant to enhance communication among navigators, patients, and providers, as well as provide easy communication channels among participants for peer support. We will examine the feasibility/acceptability of the intervention with more traditional navigation support and examine preliminary data regarding its potential efficacy in engaging women in PrEP and MOUD. For the pilot test, we will: 1. Conduct a pilot test with women who have recently been incarcerated (n=60) in Philadelphia randomized to an "Enhanced" intervention that includes patient navigation with the PA-Links web-based app + navigation, compared to a "Basic" intervention that includes existing navigation. To assess promise of efficacy, we will compare linkage to PrEP and MOUD (primary outcomes) during the three-month intervention at immediate post and 3-month follow-up and assess self-reported knowledge and attitudes. Qualitative exit interviews will inform feasibility and acceptability.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
74
The PA Links application is a web-based application (meaning it does not have to be downloaded to a smart phone and can be accessed via a URL link from any device connected to the Internet). This design ensures broader access and avoids excluding individuals without smartphones. This was developed along with our technology partner Nurelm (https://nurelm.com/). Women randomized to this arm of the intervention will go through an onboarding session to assist them in creating a unique login username and password to the PA Links system (see onboarding document attached). Only those with a registered username and password can access and use the PA Links system and Nurelm will not be able to access the application after it is "live" for the pilot RCT. The application will be housed on the AWS server, which also does not have access to data or information in the app.
Temple University
Philadelphia, Pennsylvania, United States
Pre-exposure Prophylaxis (PrEP) linkage
Assess via medical record whether participant has been linked to PrEP services. Yes/No
Time frame: Immediate post intervention (3 months)
Medications for Opioid Use Disorder (MOUD) Linkage
Assess via medical record whether participant has been linked to MOUD services. Yes/No
Time frame: Immediate post intervention (3 months)
Engagement with intervention
Number and types of contact with navigator. Gotten from app data and EMR navigator reports
Time frame: Immediate post intervention (3 months)
Usability of PA-Links
User logs on what parts of application were used most; Survey questions asking which parts of app they used, yes/no.
Time frame: Immediate post intervention (3 months)
PrEP treatment referral
Accepted referral to PrEP. Data from FIGHT EMR. Yes/no
Time frame: Immediate post intervention (3 months); Three month post intervention follow-up (six months)
MOUD treatment referral
Accepted MOUD treatment referral. Data from FIGHT EMR. Yes/No
Time frame: Immediate post intervention (3 months); Three month post intervention follow-up (six months)
HIV Risk
Self reported HIV behavior risk. Using the HIV Risk-Taking Behavior Scale. This scale is 11 items, assessing drug use and sexual behavior risk. Responses to each item are coded on a 6-point scale from 0 to 5, with higher values associated with more risky behaviors. Summary scores are obtained by adding up the ordinal values of responses obtained; a score of 0 would indicate no risky behaviors and a score of 55 would indicate maximal risky behaviors.
Time frame: Baseline, before intervention begins; Immediate post intervention (3 months); Three month post intervention follow-up (six months)
Overdose risk
Overdose risk and experience during intervention. Based on the Overdose Risk self-assessment, participants are asked about overdose risks answering yes or no. The more yes responses indicates a higher overdose risk.
Time frame: Baseline, before intervention begins; Immediate post intervention (3 months); Three month post intervention follow-up (six months)
PrEP perceptions
Perceptions of barriers and benefits to PrEP use. Study created scales - 12 statements on the benefits of using PrEP and 12 statements on barriers to using PrEP, answered on a zero -10 scale. Higher numbers mean higher agreement with the statement. These will be compared at the time points to assess if there is an increase in perceived benefits and a decrease in perceived barriers.
Time frame: Baseline, before intervention begins; Immediate post intervention (3 months); Three month post intervention follow-up (six months)
MOUD perceptions
Perceptions of barriers and benefits to MOUD use. Study created scales - 11 statements on the benefits of using MOUD and 10 statements on barriers to using MOUD, answered on a zero -10 scale. Higher numbers mean higher agreement with the statement. These will be compared at the time points to assess if there is an increase in perceived benefits and a decrease in perceived barriers.
Time frame: Baseline before intervention begins; Immediate post intervention (3 months); Three month intervention followup (6 months)
Time to Linkage of PrEP
Time in months from navigator first contact to linkage to PrEP. EMR data from FIGHT.
Time frame: Immediate post intervention (3 months); Three month post intervention follow-up (six months)
Receipt of prescription of PrEP
Receipt of prescription of PrEP. EMR data from FIGHT. Yes/no
Time frame: Immediate post intervention (3 months); Three month post intervention follow-up (six months)
Filling of PrEP prescription
If PrEP prescription was filled. EMR data from FIGHT. Yes/No
Time frame: Immediate post intervention (3 months); Three month post intervention follow-up (six months)
PrEP adherence
Assess if participant is being adherent to PrEP based on FIGHT EMR data. Could be physician notes or blood work results, if taken. Yes/No
Time frame: Immediate post intervention (3 months); 3 months intervention follow up (6 months)
PrEP knowledge
True/False statements about PrEP. Five statements about PrEP. A composite score based on the number of correct answers will be assessed and compared across timepoints.
Time frame: Baseline; Immediate intervention post-test (3 months); 3 month intervention follow-up (6 months)
Time to MOUD Linkage
Time in months from navigator first contact to linkage to MOUD. EMR data from FIGHT.
Time frame: Immediate post intervention (3 months); Three month post intervention follow-up (six months)
Receipt of MOUD Prescription
Receipt of MOUD prescription. EMR data from FIGHT. Yes/no
Time frame: Immediate post intervention (3 months); 3 month post intervention follow-up (6 months)
Filling of MOUD prescription
Filling of MOUD prescription. EMR data from FIGHT. Yes/no
Time frame: Immediate post intervention (3 months); 3 months intervention follow up (6 months)
MOUD adherence
Assess if participant in adherent to MOUD based on FIGHT EMR data. Could be from physician notes or blood work, if taken. Yes/No
Time frame: Immediate post intervention (3 months); 3 months intervention follow up (6 months)
MOUD Knowledge
True/False statements about MOUD. Five statements about MOUD. A composite score based on the number of correct answers will be assessed and compared across timepoints.
Time frame: Baseline; Immediate intervention post -test (3 months); 3 month intervention follow-up (six months)
Client Intervention Satisfaction
Assessed via survey using five items from the the Study Participant Feedback Questionnaire. Two items are yes/no answers. Yes answers indicate they agree they were informed about the study. Three questions are on a 0-4 scale, with a zero indicating they strongly disagree with the statement and a 4 that they strongly agree. Higher number answers indicate higher intervention satisfaction.
Time frame: Immediate post intervention (3 months)
mHealth feasibility/satisfaction
Assessed using the mHealth App Usability Questionnaire (MAUQ). It is a 21 item scale, with 8 items that assess Ease of use and satisfaction; 6 items on system information arrangement, and 7 items on usefulness. All use a 1 to 7 scale, indicating amount of agreement with a 7 as strongly agree. Each individual item will be assessed and a composite score for each area will also be assessed.
Time frame: Immediate post intervention (3 months)
Usability of mHealth app
Assessed using the Usability of e-health interventions scale. It consists of 10 items scored on a 1-5 scale, indicating level of agreement, with a 5 meaning they strongly agree with the statement. The higher the score, the more they agree that the app was usable.
Time frame: Immediate post intervention (3 months)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.